Second-generation tau PET tracer in situ binding assessed with fluorescence imaging
Abstract
Brain positron emission tomography (PET) imaging is a valuable tool which allows visualization of the pathological structures inside the living patients’ brains. While amyloid-β PET tracers have been in use with Alzheimer’s disease patients in clinics, tau PET tracers have still not entered the clinical routine. Second-generation tau PET tracers have been developed with the aim to overcome the limitations of the first-generation tau PET tracers, such as low sensitivity and off-target binding. However, the detailed pathological characterization of these tracers’ binding is still needed for fully understanding their potential as accurate markers of pathogenic tau. Herein, we focused on the second-generation tau PET tracer Genentech Tau Probe 1 ([ 18 F]GTP1) and made use of the fluorescent properties of its non-radioactive unlabeled variant GTP1 for correlative fluorescence microscopy. The results show that GTP1 binds to tau tangles and neuropil threads (NPTs), but not amyloid-β plaques. Importantly, our results indicate that there is a strong correlation between the fluorescent GTP1 signal and the [ 18 F]GTP1 signal detected with autoradiography, which is currently the standard way of studying the tau PET tracer binding in situ . Together, this data shows the robust application of a non-radioactive tau PET tracer in binding studies in post-mortem tissue and sheds new light on the tau binding properties of GTP1.
Related
- Quanta microscopy enables fluorescence imaging at the native bit-plane rate
- Multi-parametric NIR-II fluorescence perfusion imaging towards quantitative stroke evaluation
- In vivo imaging of autophagy dynamics in the intact mammalian brain using a fluorescence lifetime-based sensor
- Optimizing x-ray based multimodal imaging: investigating dose dependency and modulation of fluorescence emission from GdF ₃ nanoparticles doped with terbium using spectral photon counting CT
- Live-Imaging of Molecular Processes with Real-Time Fluorescence Microscopy
BibTeX
@misc{antic2026secondgeneration,
title = {{Second-generation tau PET tracer in situ binding assessed with fluorescence imaging}},
author = {Aleksandra Antic and Ambra Dreos and Tammaryn Lashley and Stephen Yong Yo-Ap and Kerstin Sander and Michael Schöll and Jörg Hanrieder},
howpublished = {Research Square},
year = {2026},
month = oct,
doi = {10.21203/rs.3.rs-11153643/v1},
url = {https://doi.org/10.21203/rs.3.rs-11153643/v1},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - Second-generation tau PET tracer in situ binding assessed with fluorescence imaging
AU - Aleksandra Antic
AU - Ambra Dreos
AU - Tammaryn Lashley
AU - Stephen Yong Yo-Ap
AU - Kerstin Sander
AU - Michael Schöll
AU - Jörg Hanrieder
PY - 2026
DA - 2026/10/27
PB - Research Square
DO - 10.21203/rs.3.rs-11153643/v1
UR - https://doi.org/10.21203/rs.3.rs-11153643/v1
AB - Brain positron emission tomography (PET) imaging is a valuable tool which allows visualization of the pathological structures inside the living patients’ brains. While amyloid-β PET tracers have been in use with Alzheimer’s disease patients in clinics, tau PET tracers have still not entered the clinical routine. Second-generation tau PET tracers have been developed with the aim to overcome the limitations of the first-generation tau PET tracers, such as low sensitivity and off-target binding. However, the detailed pathological characterization of these tracers’ binding is still needed for fully understanding their potential as accurate markers of pathogenic tau. Herein, we focused on the second-generation tau PET tracer Genentech Tau Probe 1 ([ 18 F]GTP1) and made use of the fluorescent properties of its non-radioactive unlabeled variant GTP1 for correlative fluorescence microscopy. The results show that GTP1 binds to tau tangles and neuropil threads (NPTs), but not amyloid-β plaques. Importantly, our results indicate that there is a strong correlation between the fluorescent GTP1 signal and the [ 18 F]GTP1 signal detected with autoradiography, which is currently the standard way of studying the tau PET tracer binding in situ . Together, this data shows the robust application of a non-radioactive tau PET tracer in binding studies in post-mortem tissue and sheds new light on the tau binding properties of GTP1.
SN - 2693-5015
ER -